Xcell Biosciences
Building products that enable propagation and gene editing in challenging cell types for clinical research and cell therapy applications. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€100—150m (Dealroom.co estimates Jan 2022.)
San Francisco California (HQ)
Authorizing premium user...